牛牛AI助手已提取核心信息
Avenue Therapeutics, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company aims for the Registration Statement to be declared effective by 5:00 p.m. Eastern time on February 1, 2024. This request was made under Rule 461 of the Securities Act of 1933, as amended. Avenue Therapeutics has authorized Rakesh Gopalan and David Wolpa, attorneys from Troutman Pepper Hamilton Sanders LLP, to modify or withdraw the acceleration request if necessary. The company has asked the SEC to confirm the effectiveness of the Registration Statement orally with its legal representatives upon declaration.
Avenue Therapeutics, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company aims for the Registration Statement to be declared effective by 5:00 p.m. Eastern time on February 1, 2024. This request was made under Rule 461 of the Securities Act of 1933, as amended. Avenue Therapeutics has authorized Rakesh Gopalan and David Wolpa, attorneys from Troutman Pepper Hamilton Sanders LLP, to modify or withdraw the acceleration request if necessary. The company has asked the SEC to confirm the effectiveness of the Registration Statement orally with its legal representatives upon declaration.
Avenue Therapeutics, Inc.已正式要求美国证券交易委员会（SEC）加快其S-3表格注册声明的生效日期。该公司的目标是在美国东部时间2024年2月1日下午 5:00 之前宣布注册声明生效。该请求是根据经修订的1933年《证券法》第461条提出的。Avenue Therapeutics已授权Troutman Pepper Hamilton Sanders LLP的律师拉克什·戈帕兰和大卫·沃尔帕在必要时修改或撤回加速请求。该公司已要求美国证券交易委员会在声明后与其法定代表人口头确认注册声明的有效性。
Avenue Therapeutics, Inc.已正式要求美国证券交易委员会（SEC）加快其S-3表格注册声明的生效日期。该公司的目标是在美国东部时间2024年2月1日下午 5:00 之前宣布注册声明生效。该请求是根据经修订的1933年《证券法》第461条提出的。Avenue Therapeutics已授权Troutman Pepper Hamilton Sanders LLP的律师拉克什·戈帕兰和大卫·沃尔帕在必要时修改或撤回加速请求。该公司已要求美国证券交易委员会在声明后与其法定代表人口头确认注册声明的有效性。
有用
没用